All articles by Chemistry World – Page 20
-
Business
Business roundup: April 2012
Pharmaceutical A pill to keep you off the pints? Source: © IStockphoto Beer today, gone tomorrow - Selincro tablets might help patients put their alcohol problems behind them Phase III trials of Selincro (nalmefene) tablets show that it outperforms placebo treatment when used to help patients with ...
-
News
Croatia to slim down funding for science journals
The Croatian government has said it will fund only the best journals, leaving some facing an uncertain future
-
Podcast
March 2012
Chemistry World podcast - March 2012 0:37- Calculations find a quadruple carbon-carbon bond4:18- Graphene sheets are made irridescent and superhydrophobic7:10- Paul Kelly discusses an accidental discovery that led to a novel fingerprinting method14:20- Cooperative chemistry gives rotaxanes with multiple rings in surprisingly high yield ...
-
Opinion
Letters: March 2012
The article ’Silver soils’ (Chemistry World, February 2012, p36) highlights some interesting recent events relating to the environmental impact of silver residues. While a wealth of evidence exists to show that silver ions are toxic to lower organisms, there is less evidence that nanocrystalline or other forms of silver present ...
-
Business
Business roundup: March 2012
Pharmaceutical Collaboration for neglected tropical diseases A group of 13 pharma companies, three national governments and several global health organisations has come together to target 10 neglected tropical diseases (NTDs) with $785 million (?497 million) in R&D funding. The group aims to ’accelerate progress toward eliminating or controlling [this set ...
-
News
EU innovation position slipping
The growth of innovation in the EU is slowing, making it more difficult for the EU to compete internationally
-
Podcast
February 2012
Chemistry World podcast - February 20121.07 - Determining the age of bloodstains using fluorescence 3.51 - Magnetic nanoparticles to remove cadmium from blood 6.07 - Paul Bertsch discusses using worms to investigate the effects of silver nanoparticles in the environment12.12 - Controlling termite populations with nanoparticle technology15.04 - Listening to ...
-
Opinion
Letters: February 2012
In his comment article, David Fox (Chemistry World, January 2012, p42) highlights the importance of having access to a well-curated repository of small molecules for drug discovery (and chemical genomics), but he feels that it is important to ’combine a well-validated target with a means of intervention that minimises attrition ...
-
Business
Business roundup: February 2012
Pharmaceutical BMS spends $2.5 billion on antiviral firm Pharma giant Bristol-Myers Squibb (BMS) has struck a deal to buy US biotech Inhibitex for $2.5 billion (?1.6 billion). The move will stock BMS’s pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating ...